Health care stocks edged higher Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.1%.
The iShares Biotechnology ETF (IBB) rose 0.4%.
In corporate news, Hoth Therapeutics (HOTH) signed an exclusive patent license agreement with the US Department of Veterans Affairs to develop an obesity treatment. The shares fell 2%.
Johnson & Johnson (JNJ) signed an exclusive licensing deal for the global development, manufacturing and commercialization of Kaken Pharmaceutical's STAT6 program for atopic dermatitis and other autoimmune and allergic diseases. Johnson & Johnson shares shed 0.2%.
TScan Therapeutics (TCRX) shares rose 3.3% after the company signed a securities purchase agreement with Lynx1 Capital Management and an investment fund advised by Lynx1 for the sale of $30 million of prefunded warrants.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。